Shell Asset Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Shell Asset Management’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,914	Closed	-$33K	–	1329
2023 Q4	$33K	Sell	12,914 -3,834	-23%	-$8.93K	﹤0.01%	1211
2023 Q3	$40K	Sell	16,748 -64	-0.4%	-$142	﹤0.01%	1213
2023 Q2	$39K	Sell	16,812 -96	-0.6%	-$271	﹤0.01%	1235
2023 Q1	$43K	Sell	16,908 -59	-0.3%	-$169	﹤0.01%	1203
2022 Q4	$43K	Sell	16,967 -961	-5%	-$2.68K	﹤0.01%	1280
2022 Q3	$52K	Sell	17,928 -2,379	-12%	-$10K	﹤0.01%	1325
2022 Q2	$92K	Buy	+20,307	New	+$121K	﹤0.01%	1301

Shell Asset Management's SLGC Position: Q1 2024 in Review

Shell Asset Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 12,914 shares — an estimated $33K sold.

Shell Asset Management first reported a position in SLGC in Q2 2022 and held it in 7 quarters. The position peaked at $92K in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Shell Asset Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Shell Asset Management sold 12,914 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $33K.
Shell Asset Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 7 quarters.
Shell Asset Management's SomaLogic, Inc. Class A Common Stock position peaked at $92K in Q2 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Shell Asset Management's 13F filing for Q1 2024, filed 14 May 2024.